Investing
Unlike other areas of crypto policy, Democrats and Republicans agree on the need for stablecoin legislation, but according to Democratic Rep. Ritchie Torres of...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
Investing
Published: March 3, 2025 at 5:34 p.m. ET A backlash over President Donald Trump’s plan to include three small and relatively risky tokens in an...
Investing
Published: Feb. 27, 2025 at 1:23 p.m. ET AMC Entertainment Holdings Inc.’s most liquid bond rallied this week, lifted by better-than-expected fourth-quarter revenue at the...
Investing
Last Updated: March 3, 2025 at 10:21 p.m. ETFirst Published: March 3, 2025 at 4:58 p.m. ET Kids who are obsessed with football may dream of...
Investing
With trillions of dollars of real estate-related debt coming due in the near future, commercial mortgage-backed securities (CMBS) are making headlines again. This has...
Investing
A nice trifecta of factors is telling investors that energy stocks are a buy: Investors hate them; insiders love them. And they’re cheap. Energy...
Investing
One mistake I’ve seen investors make time and time again is leaning too heavily on the latest “investment product” their bank is pitching them....
Investing
Gold prices declined on Thursday, ending below $1,950 an ounce, a day after the Federal Reserve’s policy decision to increase rates to the highest...
Investing
Oil futures rose Thursday, with the U.S. crude benchmark ending above the $80-a-barrel threshold for the first time in three months as investors looked...
Investing
By Joe Hoppe AstraZeneca on Friday reported a significant rise in second-quarter net profit, but missed market forecasts, and backed its full-year guidance. The...
Investing
By Mauro Orru British oil-and-gas major BP signed a long-term sale and purchase agreement with Austria’s OMV for the supply of liquefied natural gas....
Investing
By Elena Vardon NatWest Group on Friday posted better-than-expected pretax profit for the second quarter of 2023 and trimmed its net interest margin guidance...
Investing
By Anthony O. Goriainoff AstraZeneca said Friday that its Alexion division will buy a portfolio of preclinical rare-disease gene therapies from Pfizer for up...
